3//SEC Filing
Novartis Institutes for BioMedical Research, Inc. 3
Accession 0001104659-18-024891
CIK 0001718108other
Filed
Apr 17, 8:00 PM ET
Accepted
Apr 18, 5:22 PM ET
Size
7.9 KB
Accession
0001104659-18-024891
Insider Transaction Report
Form 3
Holdings
Series A-1 Preferred Stock
→ Common Stock (909,090 underlying)Series A Preferred Stock
→ Common Stock (2,272,726 underlying)
Footnotes (3)
- [F1]The 1,571,429 shares of Series A Preferred Stock held by the Reporting Person will automatically convert upon the closing of the Issuer's initial public offering into the number of shares of the Issuer's Common Stock shown in column 3 without payment or further consideration. The shares have no expiration date.
- [F2]The shares are held directly by Novartis Institutes for BioMedical Research, Inc. ("NIBRI"). NIBRI is an indirect wholly-owned subsidiary of, and controlled by, Novartis AG.
- [F3]The 5,214,286 shares of Series A-1 Preferred Stock held by the Reporting Person will automatically convert upon the closing of the Issuer's initial public offering into the number of shares of the Issuer's Common Stock shown in column 3 without payment or further consideration. The shares have no expiration date.
Documents
Issuer
Surface Oncology, Inc.
CIK 0001718108
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001673852
Filing Metadata
- Form type
- 3
- Filed
- Apr 17, 8:00 PM ET
- Accepted
- Apr 18, 5:22 PM ET
- Size
- 7.9 KB